SEC Filing Summary for BioCardia, Inc. (BCDA)

This filing details transactions by David McClung, Chief Financial Officer of BioCardia, Inc. On July 2, 2026, 23,125 shares of Common Stock were disposed of (transaction code F), with a price per share of 1.24. This disposal was to satisfy tax obligations related to vested RSUs. Following this, 114,245 shares remain. Additionally, on July 6, 2026, an option to buy 41,501 shares of Common Stock was acquired (transaction code A) at a price of 0.0. This option vests monthly starting August 6, 2026, with 87,841 shares owned post-transaction. The reported securities represent shares withheld for tax purposes and do not indicate a sale by the reporting person. The option vests incrementally over 48 months.